These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7589142)

  • 1. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
    Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R
    Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S; Barel M; Frade R
    J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively.
    Barel M; Balbo M; Le Romancer M; Frade R
    Eur J Immunol; 2003 Sep; 33(9):2557-66. PubMed ID: 12938232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
    Prodinger WM; Larcher C; Schwendinger M; Dierich MP
    J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoprotein.
    Delcayre AX; Fiandino A; Barel M; Frade R
    Eur J Immunol; 1987 Dec; 17(12):1827-33. PubMed ID: 2446881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
    Siaw MF; Nemerow GR; Cooper NR
    J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases.
    D'Addario M; Ahmad A; Morgan A; Menezes J
    J Mol Biol; 2000 May; 298(5):765-78. PubMed ID: 10801347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
    Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
    J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry.
    Rask R; Rasmussen JM; Hansen HV; Bysted P; Svehag SE
    J Clin Lab Immunol; 1988 Mar; 25(3):153-6. PubMed ID: 2969415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C; Cooper NR; Nemerow GR
    J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against gp140, the Epstein-Barr virus and C3d receptor in sera from rheumatoid arthritis patients.
    Barel M; Kahan A; Charriaut-Marlangue C; Kahan A; Frade R
    Eur J Immunol; 1986 Nov; 16(11):1357-61. PubMed ID: 2946590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.